Thomas Schroeder

7.1k total citations
143 papers, 2.8k citations indexed

About

Thomas Schroeder is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Schroeder has authored 143 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Hematology, 40 papers in Genetics and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Schroeder's work include Acute Myeloid Leukemia Research (76 papers), Hematopoietic Stem Cell Transplantation (52 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers). Thomas Schroeder is often cited by papers focused on Acute Myeloid Leukemia Research (76 papers), Hematopoietic Stem Cell Transplantation (52 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers). Thomas Schroeder collaborates with scholars based in Germany, United States and France. Thomas Schroeder's co-authors include Rainer Haas, Guido Kobbe, Pao‐Shin Chu, Ulrich Germing, Christina Rautenberg, Ulrich Germing, Roland Fenk, Stefanie Geyh, Ingmar Bruns and Duane E. Stevens and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Geophysical Research Atmospheres and Blood.

In The Last Decade

Thomas Schroeder

128 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Schroeder Germany	30	1.6k	596	566	426	418	143	2.8k
Gerhard Held Germany	32	540 0.3×	588 1.0×	515 0.9×	840 2.0×	445 1.1×	145	3.8k
DE Williams United States	35	1.1k 0.7×	981 1.6×	403 0.7×	1.4k 3.4×	441 1.1×	101	4.1k
Tor Knutsen Norway	32	350 0.2×	1.0k 1.7×	321 0.6×	194 0.5×	797 1.9×	97	3.3k
Charles M. Rubin United States	33	636 0.4×	520 0.9×	381 0.7×	211 0.5×	68 0.2×	87	4.6k
Wenting Wu United States	37	438 0.3×	1.3k 2.3×	2.0k 3.5×	268 0.6×	415 1.0×	116	4.2k
André Larochelle United States	29	1.4k 0.8×	1.5k 2.4×	506 0.9×	728 1.7×	43 0.1×	119	3.5k
Graeme Smith United Kingdom	21	967 0.6×	387 0.6×	632 1.1×	228 0.5×	87 0.2×	61	2.1k
Fernando Ugarte Greenland	18	328 0.2×	589 1.0×	177 0.3×	208 0.5×	131 0.3×	32	1.7k
Younghun Jung South Korea	25	692 0.4×	840 1.4×	423 0.7×	568 1.3×	220 0.5×	71	3.0k
Guiying Nie Australia	37	166 0.1×	1.1k 1.8×	225 0.4×	1.5k 3.4×	374 0.9×	138	4.1k

Countries citing papers authored by Thomas Schroeder

Since Specialization

Citations

This map shows the geographic impact of Thomas Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schroeder more than expected).

Fields of papers citing papers by Thomas Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schroeder. The network helps show where Thomas Schroeder may publish in the future.

Co-authorship network of co-authors of Thomas Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schroeder. A scholar is included among the top collaborators of Thomas Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schroeder. Thomas Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dachy, Guillaume, Myriam Labopin, Gèrard Socié, et al.. (2025). Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML. Bone Marrow Transplantation. 60(9). 1258–1264.

Schroeder, Thomas, et al.. (2025). Video Narrative Exposure Therapy (NET) with Children and Young People who Witnessed Domestic Violence: A Naturalistic Single Case Study Series. Journal of Child & Adolescent Trauma. 18(2). 447–465. 1 indexed citations

Sadowska‐Klasa, Alicja, Jan Maciej Zaucha, Myriam Labopin, et al.. (2024). Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry. Bone Marrow Transplantation. 59(3). 387–394.

Koch, Annemarie, Roland Fenk, Uwe Maus, et al.. (2024). Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Advances. 8(10). 2575–2588. 4 indexed citations

Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2024). How risky is a second allogeneic stem cell transplantation?. Leukemia. 38(8). 1799–1807. 4 indexed citations

Maffini, Enrico, Myriam Labopin, Nicolaus Kröger, et al.. (2024). Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 59(7). 983–990. 6 indexed citations

Gagelmann, Nico, Matthias Stelljes, Igor Wolfgang Blau, et al.. (2024). Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation. American Journal of Hematology. 99(8). 1540–1549. 2 indexed citations

Galimard, Jacques‐Emmanuel, Ali Bazarbachi, Jürgen Finke, et al.. (2024). Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients. Blood Cancer Journal. 14(1). 76–76. 3 indexed citations

Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2024). ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?. Leukemia. 38(5). 1156–1163. 13 indexed citations

10.

Ruutu, Tapani, Christophe Peczynski, Nicolaus Kröger, et al.. (2023). The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party. Bone Marrow Transplantation. 59(2). 255–263. 3 indexed citations

11.

Nagler, Arnon, Myriam Labopin, Nicolaus Kröger, et al.. (2023). The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT. Bone Marrow Transplantation. 58(12). 1339–1347.

12.

Gagelmann, Nico, Anita Badbaran, Rachel B. Salit, et al.. (2023). Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood. 141(23). 2901–2911. 15 indexed citations

13.

Nagler, Arnon, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2022). Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT. Bone Marrow Transplantation. 57(12). 1788–1796. 5 indexed citations

14.

Labopin, Myriam, Sebastian Giebel, Thomas Schroeder, et al.. (2022). Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(3). 282–287. 1 indexed citations

15.

Rautenberg, Christina, Michael Lauseker, Jennifer Kaivers, et al.. (2021). Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. European Journal Of Haematology. 107(2). 283–292. 15 indexed citations

16.

Schroeder, Thomas, et al.. (2021). Metastasis of Rectal Adenocarcinoma to the Penis and Scrotum in an Adult. Cureus. 13(10). e18454–e18454. 1 indexed citations

17.

Germing, Ulrich, Thomas Schroeder, Jennifer Kaivers, et al.. (2019). Novel therapies in low- and high-risk myelodysplastic syndrome. Expert Review of Hematology. 12(10). 893–908. 14 indexed citations

18.

Schroeder, Thomas, Michael Lauseker, Christina Rautenberg, et al.. (2019). Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 25(8). 1550–1559. 43 indexed citations

19.

Neukirchen, Judith, Ariane Dienst, Kathrin Nachtkamp, et al.. (2016). Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience. Blood. 128(22). 3460–3460. 3 indexed citations

20.

Blondeau‐Patissier, David, Vittorio Brando, Arnold G. Dekker, et al.. (2010). Phytoplankton response to episodic events and long-term trends in the Great Barrier Reef lagoonal waters: towards a regional characterization. European Journal of Pharmacology. 806. 43–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact